COGENT BIOSCIENCES INC (COGT)
US19240Q2012 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -192.41M | -140.24M | -72.27M | -74.81M | -31.83M | |||
| Depreciation Amortization | 2.27M | 840.00K | 150.00K | 720.00K | 1.29M | |||
| Change In Working Capital | 11.44M | 750.00K | 2.02M | -5.32M | -14.08M | |||
| Other non cash items | 25.07M | 20.01M | 11.34M | 43.55M | 3.11M | |||
| OPERATING CASH FLOW | -153.62M | -118.64M | -58.76M | -35.85M | -41.51M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -2.80M | -6.86M | -1.72M | 0.00 | -30.00K | |||
| Other Investing Activity | -95.03M | -117.86M | 0.00 | 8.42M | 23.19M | |||
| INVESTING CASH FLOW | -97.82M | -124.72M | -1.72M | 8.42M | 23.16M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 163.54M | 163.56M | 38.06M | 232.20M | 110.00K | |||
| Other Financing Activity | 0.00 | 0.00 | -90.00K | N/A | N/A | |||
| FINANCING CASH FLOW | 163.54M | 163.56M | 37.98M | 232.20M | 110.00K | |||
| CHANGE IN CASH | -87.91M | -79.80M | -22.50M | 204.77M | -18.24M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -153.62M | -118.64M | -58.76M | -35.85M | -41.51M | |||
| Capital Expenditure | -2.80M | -6.86M | -1.72M | 0.00 | -30.00K | |||
| FREE CASH FLOW | -156.42M | -125.50M | -60.48M | -35.85M | -41.54M | |||
All data in USD